Back to Search
Start Over
Memory Pharmaceuticals starts dosing in trial of calcium channel blocker in bipolar disorder
- Source :
- Health & Medicine Week. October 2, 2006, p189.
- Publication Year :
- 2006
-
Abstract
- Memory Pharmaceuticals Corp. (MEMY) announced the dosing of the first subject in a phase 2a trial of MEM 1003 in patients with acute mania in bipolar disorder. The company is [...]
Details
- Language :
- English
- ISSN :
- 15316459
- Database :
- Gale General OneFile
- Journal :
- Health & Medicine Week
- Publication Type :
- News
- Accession number :
- edsgcl.212299056